Concepedia
Statistics
Publications
5
Citations
136
H-Index
Active since
2016
Affiliations
Ulsan University Hospital(Current)
University of Ulsan
Ulsan College
Gachon University Gil Medical Center
Jeong Yi Kim is an author at Ulsan University Hospital specializing in medicine, cell biology, and cell signaling.
Top concepts
MedicineCell BiologyCell DeathCell SignalingCancer ResearchOncologyApoptosisImmunologyPharmacologyMolecular Signaling
Publications per year
2016–2018
Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
Sook‐Kyoung Heo, Eui‐Kyu Noh, Jeong Yi Kim et al. · Scientific Reports · 2017 · 67 citations · Full text
Hematological Malignancy, Tumor Biology, Chronic Myeloid Leukemia +13
LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells
Sook‐Kyoung Heo, Eui‐Kyu Noh, Gi-Dong Gwon et al. · PLoS ONE · 2016 · 21 citations · Full text
Adult Stem Cell, Immune Regulation, Immunology +23
Rhein augments ATRA-induced differentiation of acute promyelocytic leukemia cells
Sook‐Kyoung Heo, Eui‐Kyu Noh, Jeong Yi Kim et al. · Phytomedicine · 2018 · 17 citations
Hematological Malignancy, Mixed-phenotype Acute Leukemia, Adult T-cell Leukemia-lymphoma +3
Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors
Sook‐Kyoung Heo, Eui‐Kyu Noh, Gi-Dong Gwon et al. · European Journal of Pharmacology · 2016 · 16 citations
Hematological Malignancy, Cdk Inhibitors, Medicine +9
Radotinib induces high cytotoxicity in c-KIT positive acute myeloid leukemia cells
Sook‐Kyoung Heo, Eui‐Kyu Noh, Jeong Yi Kim et al. · European Journal of Pharmacology · 2017 · 15 citations
Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +6
1–5 of 5